The benefits of immunotherapy and the impact of available therapies for metastatic melanoma on the clinical outcome of patients in the Unified Health System (SUS). (2025). Research, Society and Development, 14(5), e5014548809. https://doi.org/10.33448/rsd-v14i5.48809